Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
27.75
-0.03 (-0.11%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer's Options: A Look at What the Big Money is Thinking
March 27, 2024
Via
Benzinga
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months
March 27, 2024
Let's review what Wall Street analysts believe are potentially the stocks to double over the next 12 months.
Via
InvestorPlace
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
March 27, 2024
Each of these three companies are entering a new era of growth.
Via
The Motley Fool
Adobe Revolutionizes Content Supply Chain With New Generative AI Tools
March 26, 2024
Adobe introduces GenStudio and Firefly, a suite of AI tools that streamline content creation and management, addressing the challenges of the content supply chain. Strategic partnerships and new...
Via
Benzinga
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Supply Chain
Pfizer Options Trading: A Deep Dive into Market Sentiment
March 21, 2024
Via
Benzinga
Is Pfizer the Best Dividend Stock for You?
March 21, 2024
Pfizer's stock is cheap, and it pays an incredibly high yield right now.
Via
The Motley Fool
Harnessing AI for Drug Discovery: Top 3 Stocks to Watch
March 26, 2024
As biotech innovators look to AI to smoothen out the drug discovery process, the leaders in the scene could stand to benefit greatly.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
March 26, 2024
If you have a Benjamin burning a hole in your pocket, these stocks are a great way to invest it.
Via
The Motley Fool
Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating
March 25, 2024
Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight.
Via
InvestorPlace
Novo Nordisk and Eli Lilly May Finally Have Some Real Competition
March 25, 2024
Novo Nordisk and Eli Lilly dominate the weight-loss market, but progress from a rising biotech could spell trouble for the pharma giants.
Via
The Motley Fool
3 Ultra-High-Yield Dividend Stocks That Could Realistically Double Your Money by 2030
March 25, 2024
There's no guarantee these stocks can generate 100% returns by 2030. But they have a clear path to make it happen.
Via
The Motley Fool
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
March 25, 2024
What's good for Wood and Ark Invest might not be good for other investors.
Via
The Motley Fool
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
March 23, 2024
The price could be right for these three biopharma stocks.
Via
The Motley Fool
7 Stocks That Will Make Your Friends Green with Envy
March 23, 2024
Discover stocks set to dazzle the market with innovative business models and disruptive technologies. Dive in for potential outperformance.
Via
InvestorPlace
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
March 23, 2024
These stocks share several things in common.
Via
The Motley Fool
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?
March 23, 2024
After a lousy year of declining prices, these stocks offer yields of 4.7% and 6.1% at recent prices.
Via
The Motley Fool
Will Pfizer Be a Trillion-Dollar Stock by 2035?
March 23, 2024
A market cap of $1 trillion for Pfizer over the next 11 or so years? Possible, but not probable.
Via
The Motley Fool
7 High-Value Stocks With Massive Wealth-Building Potential
March 22, 2024
Explore high-value stocks shaping the future across semiconductors, digital payments, AI, and healthcare for savvy investors.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
March 22, 2024
Legal actions surge against diabetes drug manufacturers Eli Lilly and Novo Nordisk. Patients allege severe complications, including gallbladder issues and gastroparesis, tied to GLP-1 agonists. Over 60...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease
March 21, 2024
Promising results from a Phase 1 trial led by NIH: scAAV9/JeT-GAN gene therapy shows potential benefits for giant axonal neuropathy. The therapy demonstrated safety and efficacy in children with GAN,...
Via
Benzinga
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
March 21, 2024
Ark, through its flagship Ark Innovation ETF and Ark Genomic Revolution ETF, has been brisk with its acquisition of Moderna shares in March.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
EXCLUSIVE: Health Care Experts Discuss Critical Need For An Equitable System
March 20, 2024
Former Pfizer CMO Dr. Freda Lewis-Hall and ICR Westwicke's Michael O'Brien discuss challenges in autoimmune disease treatment and healthcare innovation.
Via
Benzinga
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
March 20, 2024
BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandemic with their jointly developed vaccine.
Via
Benzinga
Exposures
COVID-19
BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts
March 20, 2024
BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance.
Via
Investor's Business Daily
Why Is BioNTech Stock Trading Lower On Wednesday?
March 20, 2024
BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5-€3.1 billion,...
Via
Benzinga
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
March 19, 2024
These dividend stocks selling for under $50 with yields of 5% or more offer a lot to investors at any time making these strong buys.
Via
InvestorPlace
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
March 18, 2024
Pfizer to reduce stake in Haleon to approximately 24% following earlier divestment announcement. Offer price per share to be revealed post book-building process by Haleon.
Via
Benzinga
7 Dangerous Dividend Stocks to Avoid at All Costs: March 2024
March 18, 2024
Lurking in the weeds like a tiger ready to strike, these dangerous dividend stocks are set to wreak havoc on any investment portfolio.
Via
InvestorPlace
5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move
March 18, 2024
Pfizer just might be one of the biggest comeback stories of the second half of this decade.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.